Security key
81642T209
SELLAS Life Sciences Group, Inc. - Common Stock (SLS)
CUSIP: 81642T209
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 178,475,456
- Total 13F shares
- 6,195,241
- Share change
- +802,010
- Total reported value
- $6,443,955
- Put/Call ratio
- 2.8%
- Price per share
- $1.04
- Number of holders
- 29
- Value change
- +$751,049
- Number of buys
- 14
- Number of sells
- 12
Report period
Q4 2024
Institutions
29
Top holders
10
SLS full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
SELLAS Life Sciences Group, Inc. SEC filings
SELLAS Life Sciences Group, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 81642T209
Recent filing periods:
Top shareholders of SLS - SELLAS Life Sciences Group, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
2,292,857
|
$2,866,071 | — | 30 Sep 2024 | |
| Anson Funds Management LP |
13F
|
Company |
0.44%
|
793,835
|
$992,294 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
605,191
|
$756,579 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.24%
|
431,618
|
$539,523 | — | 30 Sep 2024 | |
| Opus Capital Group, LLC |
13F
|
Company |
0.13%
|
226,100
|
$283,000 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.1%
|
174,529
|
$218,161 | — | 30 Sep 2024 | |
| Diametric Capital, LP |
13F
|
Company |
0.09%
|
160,194
|
$200,242 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
100,843
|
$126,054 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
92,937
|
$116,171 | — | 30 Sep 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.04%
|
79,241
|
$99,000 | — | 30 Sep 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.04%
|
62,785
|
$78,481 | — | 30 Sep 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
58,338
|
$72,923 | — | 30 Sep 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.03%
|
51,894
|
$64,868 | — | 30 Sep 2024 | |
| Mariner, LLC |
13F
|
Company |
0.03%
|
47,429
|
$59,286 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
47,319
|
$59,149 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
46,335
|
$57,919 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
17,435
|
$21,794 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.01%
|
16,591
|
$20,739 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
16,238
|
$20,298 | — | 30 Sep 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.01%
|
15,554
|
$19,000 | — | 30 Sep 2024 | |
| CALTON & ASSOCIATES, INC. |
13F
|
Company |
0.01%
|
14,000
|
$17,500 | — | 30 Sep 2024 | |
| Equitable Holdings, Inc. |
13F
|
Company |
0.01%
|
12,060
|
$15,075 | — | 30 Sep 2024 | |
| Nemes Rush Group LLC |
13F
|
Company |
0.01%
|
10,000
|
$10,100 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
5,789
|
$7,236 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,709
|
$4,636 | — | 30 Sep 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,660
|
$2,075 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
526
|
$658 | — | 30 Sep 2024 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
374
|
$471 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
187
|
$233 | — | 30 Sep 2024 | |
| Parkside Financial Bank & Trust |
13F
|
Company |
0%
|
2
|
$3 | — | 30 Sep 2024 | |
| Barbara A. Wood |
3/4/5
|
EVP, Gen. Counsel, Corp. Sec. |
—
mixed-class rows
|
249,450
mixed-class rows
|
$821,565 | — | 22 Jan 2024 | |
| Robert Francomano |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
91,836
mixed-class rows
|
$278,365 | — | 22 Jan 2024 |
Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock (SLS) as of Q4 2024
As of 31 Dec 2024,
SELLAS Life Sciences Group, Inc. - Common Stock (SLS) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,195,241 shares.
The largest 10 holders included
VANGUARD GROUP INC, Anson Funds Management LP, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, BlackRock, Inc., Opus Capital Group, LLC, STATE STREET CORP, NORTHERN TRUST CORP, UBS Group AG, and XTX Topco Ltd.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
30
Q4 2024 holders
29
Holder diff
-1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.